Effectiveness of Ramucirumab Plus Docetaxel for Advanced Non-Small Cell Lung Cancer Patients: a Cohort of 93 Patients

被引：0
|
作者：
Barcelos, Isabella Favato [1 ]
De Marchi, Pedro [1 ]
Aguiar Junior, Pedro Nazareth [1 ]
Montella, Tatiane Caldas [1 ]
Afonso, Nathalia Gimenes [1 ]
Visani, Filipe [1 ]
Negreiros, Izabella Santos [1 ]
De Cerqueira Mathias, Clarissa Maria [1 ]
Paes, Rafael Duarte [1 ]
Dienstmann, Rodrigo [1 ]
Ferreira, Carlos Gil [1 ]
机构：
[1] Oncoclin, Rio De Janeiro, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.11
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [1] The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer
    Sakaguchi, Tadashi
    Furuya, Naoki
    Ito, Kentaro
    Hida, Naoya
    Morikawa, Kei
    Komase, Yuko
    Inoue, Takeo
    Hataji, Osamu
    Mineshita, Masamichi
    THORACIC CANCER, 2020, 11 (06) : 1559 - 1565
  • [2] Efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer: A multicenter retrospective cohort study
    Matsumoto, Kinnosuke
    Tamiya, Akihiro
    Inagaki, Yuji
    Taniguchi, Yoshihiko
    Matsuda, Yoshinobu
    Kawachi, Hayato
    Tamiya, Motohiro
    Tanizaki, Satoshi
    Uchida, Junji
    Ueno, Kiyonobu
    Yanase, Takafumi
    Suzuki, Hidekazu
    Atagi, Shinji
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (02) : 207 - 213
  • [3] Impact of docetaxel plus ramucirumab therapy on interstitial lung disease in recurrent advanced non-small cell lung cancer patients
    Ebi, Noriyuki
    Inoue, Hiroyuki
    Fujimoto, Yuta
    Chen, Maiya
    Sanai, Rei
    Kushima, Natsumi
    Osaki, Yusuke
    Ikeda, Takato
    Nakao, Akira
    Shundo, Yuki
    Yanagihara, Toyoshi
    Hamada, Naoki
    Fujita, Masaki
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (10)
  • [4] Efficacy and Safety of Docetaxel plus Ramucirumab for Patients with Pretreated Advanced or Recurrent Non-small Cell Lung Cancer: Focus on Older Patients
    Onoi, Keisuke
    Yamada, Tadaaki
    Morimoto, Kenji
    Kawachi, Hayato
    Tsutsumi, Rei
    Takeda, Takayuki
    Okada, Asuka
    Tamiya, Nobuyo
    Chihara, Yusuke
    Shiotsu, Shinsuke
    Takemura, Yoshizumi
    Yamada, Takahiro
    Hasegawa, Isao
    Katayama, Yuki
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Takayama, Koichi
    TARGETED ONCOLOGY, 2024, 19 (03) : 411 - 421
  • [5] Cost-effectiveness analysis of pegfilgrastim in patients with non-small cell lung cancer receiving ramucirumab plus docetaxel in Japan
    Kondo, Yu
    Tachi, Tomoya
    Sakakibara, Takayoshi
    Kato, Jun
    Kato, Aki
    Mizuno, Takahito
    Miyake, Yoshio
    Teramachi, Hitomi
    SUPPORTIVE CARE IN CANCER, 2022, 30 (08) : 6775 - 6783
  • [6] Cost-effectiveness analysis of pegfilgrastim in patients with non-small cell lung cancer receiving ramucirumab plus docetaxel in Japan
    Yu Kondo
    Tomoya Tachi
    Takayoshi Sakakibara
    Jun Kato
    Aki Kato
    Takahito Mizuno
    Yoshio Miyake
    Hitomi Teramachi
    Supportive Care in Cancer, 2022, 30 : 6775 - 6783
  • [7] Sequencing of Ramucirumab plus Docetaxel Post-Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer Patients
    Clarke, J.
    Stefaniak, V.
    Batus, M.
    Winfree, K.
    Molife, C.
    Cui, Z.
    Han, Y.
    Tawney, M.
    Bonomi, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S874 - S874
  • [8] Ramucirumab plus Docetaxel Usage Following Rapid Disease Progression in Real World Advanced Non-Small Cell Lung Cancer Patients
    Batus, M.
    Molife, C.
    Clarke, J.
    Stefaniak, V.
    Winfree, K.
    Cui, Z.
    Han, Y.
    Tawney, M.
    Bonomi, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S669 - S669
  • [9] Efficacy of subsequent docetaxel plus /- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer
    Tamura, Nobumasa
    Horinouchi, Hidehito
    Sekine, Katsutoshi
    Matsumoto, Yuji
    Murakami, Shuji
    Goto, Yasushi
    Kanda, Shintaro
    Fujiwara, Yutaka
    Yamamoto, Noboru
    Ohe, Yuichiro
    THORACIC CANCER, 2019, 10 (05) : 1141 - 1148
  • [10] Impact of ramucirumab pharmacokinetics in combination with docetaxel on the efficacy and survival in patients with advanced non-small cell lung cancer
    Akagi, Kazumasa
    Yagishita, Shigehiro
    Ohuchi, Mayu
    Hayashi, Yoshiharu
    Takeyasu, Yuki
    Masuda, Ken
    Shinno, Yuki
    Okuma, Yusuke
    Yoshida, Tatsuya
    Goto, Yasushi
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Mukae, Hiroshi
    Ohe, Yuichiro
    Hamada, Akinobu
    LUNG CANCER, 2023, 178 : 247 - 253
12345